GS
GAM Systematic’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $1.68M | Buy |
5,369
+1,688
| +46% | +$529K | 0.24% | 149 |
|
|
2017
Q2 | $999K | Sell |
3,681
-257
| -7% | -$69.7K | 0.14% | 287 |
|
|
2017
Q1 | $1.08M | Buy |
3,938
+1,639
| +71% | +$448K | 0.21% | 184 |
|
|
2016
Q4 | $652K | Sell |
2,299
-21
| -0.9% | -$5.96K | 0.15% | 272 |
|
|
2016
Q3 | $726K | Buy |
2,320
+1,614
| +229% | +$505K | 0.15% | 278 |
|
|
2016
Q2 | $171K | Sell |
706
-275
| -28% | -$66.6K | 0.04% | 517 |
|
|
2016
Q1 | $255K | Sell |
981
-957
| -49% | -$249K | 0.07% | 438 |
|
|
2015
Q4 | $594K | Buy |
1,938
+1,150
| +146% | +$352K | 0.17% | 247 |
|
|
2015
Q3 | $230K | Sell |
788
-1,536
| -66% | -$448K | 0.05% | 487 |
|
|
2015
Q2 | $939K | Buy |
2,324
+1,654
| +247% | +$668K | 0.12% | 268 |
|
|
2015
Q1 | $283K | Buy |
670
+644
| +2,477% | +$272K | 0.04% | 335 |
|
|
2014
Q4 | $9K | Buy |
+26
| New | +$9K | ﹤0.01% | 383 |
|